These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22707671)

  • 1. Note of clarification of data in the meta-analysis of methylenetetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
    Chan Y; Zi F; Wu X; Ma L; Meng Y; Chen J; Wang S; Luo S; Luo Y; Tang W
    Mol Hum Reprod; 2012 Oct; 18(10):514-5. PubMed ID: 22707671
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
    Bagos PG
    Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
    Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M
    Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk.
    Wu JB; Zhai JF; Yang J
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28081274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome.
    Radaković B; Goldstajn MS
    Coll Antropol; 2007 Sep; 31(3):919-21. PubMed ID: 18041407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in preoperative myocardial infarction.
    Senol S; Es MU; Gokmen G; Ercin O; Tuylu BA; Kargun K
    Asian Cardiovasc Thorac Ann; 2015 May; 23(4):389-93. PubMed ID: 25122721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
    Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of methylenetetrahydrofolate reductase gene polymorphisms with polycystic ovary syndrome].
    Qi Q; Zhang H; Yu M; Wang X; Wang Z; Xu L; Wang J; Mu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):400-4. PubMed ID: 26037361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
    Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
    J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an association between the development of metabolic syndrome in PCOS patients and the C677T MTHFR gene polymorphism?
    Ożegowska K; Bogacz A; Bartkowiak-Wieczorek J; Seremak-Mrozikiewicz A; Pawelczyk L
    Ginekol Pol; 2016; 87(4):246-53. PubMed ID: 27321094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss.
    Jeddi-Tehrani M; Torabi R; Zarnani AH; Mohammadzadeh A; Arefi S; Zeraati H; Akhondi MM; Chamani-Tabriz L; Idali F; Emami S; Zarei S
    Am J Reprod Immunol; 2011 Aug; 66(2):149-56. PubMed ID: 21241403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between 4G and 5G genetypes distribution of plasminogen activator inhibitor-1 gene polymorphism in its promoter region with polycystic ovarian syndrome].
    Zhao JL; Chen ZJ; Zhao YR; Zhao LX; Wang LC; Tang R; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):528-31. PubMed ID: 16202290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase C677T polymorphism in breast cancer risk.
    Eroğlu A; Akar N
    Breast Cancer Res Treat; 2010 Aug; 122(3):897-8. PubMed ID: 20467892
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to preeclampsia: the need for data clarification in a recent meta-analysis.
    Xuan C; Lun LM
    Hypertens Res; 2013 May; 36(5):463-4. PubMed ID: 23324864
    [No Abstract]   [Full Text] [Related]  

  • 16. Two cousins with neonatal stroke, PAI-1 4G variant and MTHFR A1298C mutation.
    Golomb MR; Heiny M; Garg BP
    J Child Neurol; 2007 Jun; 22(6):753-5. PubMed ID: 17641264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in MTHFR, MTHFD, and PAI-1 and recurrent miscarriage among North Indian women.
    Parveen F; Tuteja M; Agrawal S
    Arch Gynecol Obstet; 2013 Nov; 288(5):1171-7. PubMed ID: 23685927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome.
    Choi SW; Gu BH; Ramakrishna S; Park JM; Baek KH
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):85-8. PubMed ID: 19427093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients.
    Al-Muhanna F; Al-Mueilo S; Al-Ali A; Larbi E; Rubaish A; Abdulmohsen MF; Al-Zahrani A; Al-Ateeq S
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):937-41. PubMed ID: 18974580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.